Survodutide 10 mg Survodutide 10 mg
Dragon Pharma

Survodutide 10 mg

SURVODUTIDE 10 MG INJECTION
Drug Class: Dual Agonist (GLP-1 + Glucagon Receptor Agonist)
Composition:
- Active Substance: Survodutide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

100.00 USD
Shipping From:
International
U.S. Domestic

Survodutide 10 mg Detailed

Lab-Tested Dragon Pharma Survodutide 10 mg

survodutide lab test report

What Is Survodutide 10 mg?

Survodutide is a dual agonist peptide targeting both GLP-1 (glucagon-like peptide-1) and glucagon receptors, developed to treat obesity and metabolic diseases. This 10 mg vial by Dragon Pharma delivers clinical-grade Survodutide designed to reduce body weight, improve insulin sensitivity, and regulate appetite.

Survodutide is currently in late-stage clinical trials and has demonstrated potent fat-reducing effects. See peer-reviewed data on Survodutide's metabolic and weight-loss benefits.

Benefits of Survodutide

  • Significant fat loss through GLP-1 + glucagon receptor activation
  • Reduces appetite and increases satiety
  • Improves insulin sensitivity and glucose metabolism
  • Supports liver fat reduction (NAFLD/MAFLD)
  • Once-weekly dosing for long-term metabolic support

This innovative compound is being researched as a next-generation solution for patients unresponsive to semaglutide or tirzepatide.

How to Use Survodutide 10 mg

Reconstitute with 1–2 mL of bacteriostatic water. Inject subcutaneously once per week. Initial dosing may begin at 2.5–5 mg weekly, with gradual increase to 10 mg or more, depending on tolerance and guidance from a health professional.

Best injected in the same area each week (abdomen or thigh), at the same time of day for consistency.

Recommended Stacks for Advanced Fat Loss

Survodutide can be combined with non-overlapping peptides for superior metabolic, recovery, or wellness results:

  • Semaglutide 5 mg – alternate or combine during titration phase
  • CJC-1295 DAC – enhances GH release for muscle tone and recovery
  • BPC 157 5 mg – supports gut health and joint recovery while cutting
  • Epitalon 50 mg – helps with circadian rhythm, hormonal balance, and longevity

This GLP-1/glucagon dual-agonist peptide by Dragon Pharma is ideal for aggressive weight management and long-term metabolic control.

Safety and Side Effects

Common side effects include nausea, fullness, constipation, or fatigue during early use. These effects typically resolve as the body adapts. Survodutide is non-stimulant and non-addictive. Always use under the supervision of a qualified provider.

Conclusion

Survodutide 10 mg for Sale represents the future of advanced fat-loss peptide therapy. This high-potency Dragon Pharma peptide is trusted by clinicians and biohackers for safe, science-based metabolic enhancement.

Frequently Asked Questions

What is Survodutide used for?

Survodutide is a dual agonist peptide targeting GLP-1 and glucagon receptors. It is used to promote fat loss, control appetite, and improve metabolic health.

How effective is Survodutide for weight loss?

Clinical studies suggest Survodutide can result in significant body fat reduction, with weight loss comparable or superior to semaglutide and tirzepatide in some patients.

How do you take Survodutide 10 mg?

Survodutide is injected subcutaneously once weekly. Dosage typically begins low (2.5–5 mg) and is increased gradually based on tolerance and desired results.

What are the side effects of Survodutide?

Common side effects include nausea, fullness, or mild GI discomfort during the first few weeks. Most users adapt quickly with minimal ongoing issues.

No reviews found

Please log in to write Survodutide 10 mg review.

Related Offers
US Domestic & International
Sermorelin 5 mg
Dragon Pharma, Europe

SERMORELIN 5 MG INJECTION
Drug Class: Growth Hormone-Releasing Hormone (GHRH)
Composition:
- Active Substance: Sermorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma

45.00 USD  
US Domestic & International
PT-141 10 mg
Dragon Pharma, Europe

BREMELANOTIDE 10 MG INJECTION
Drug Class: Selective Melanocortin Receptor Agonist
Composition:
- Active Substance: Bremelanotide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma

45.00 USD  
Lab Tested
US Domestic & International
BPC 157 5 mg
Dragon Pharma, Europe

PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 5 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

40.00 USD  
US Domestic & International
Tesamorelin 5 mg
Dragon Pharma, Europe

TESAMORELIN 5 MG INJECTION
Drug Class: Growth Hormone-Releasing Hormone (GHRH)
Composition:
- Active Substance: Tesamorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma

70.00 USD  
Lab Tested
US Domestic & International
Tirze-Pep 5 mg
Dragon Pharma, Europe

TIRZE-PEP 5 MG INJECTION
Drug Class: Dual GLP-1/GIP Peptide
Composition:
- Active Substance: Tirzepatide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

90.00 USD  

Add in Cart - Product(s)

Close Button
Empty

Total Cost: